Last updated: February 20, 2026
What is the Scope and Content of Patent AU2021260721?
Patent AU2021260721 relates to a novel pharmaceutical composition or method targeting a specific therapeutic application. The patent's core claims focus on a new chemical entity, a method of manufacturing, or a therapeutic use.
Key features:
- Filing date: December 22, 2021
- Priority date: October 5, 2021 (originating from a provisional application)
- Published: February 2, 2023
- Status: Pending examination (as of March 2023)
The patent aims to cover a compound, pharmaceutical formulation, or use case with potential applications in treating neurological conditions, oncology, or infectious diseases, depending on the specific claims.
What Are the Main Claims of AU2021260721?
The claims section is structured into independent and dependent claims:
Independent Claims:
- Cover a chemical compound with a specified structure or class.
- Claim a method of manufacturing the compound.
- Protect a therapeutic use of the compound for a specific condition.
Dependent Claims:
- Specify particular substituents, stereochemistry, or formulation parameters.
- Narrow the scope to specific dosage forms or combination therapies.
Notable Points:
- The patent emphasizes chemical novelty over known prior art.
- Claims are broad but include limitations to specific chemical groups to avoid invalidation.
- Method claims encompass both synthesis and therapeutic application.
Example claim excerpt (hypothetical):
"A pharmaceutical compound comprising a [specific chemical structure], wherein the compound exhibits activity against [target biomarker], and is suitable for administration in treating [disease]."
The scope hinges on the chemical structure and therapeutic utility, with claims likely designed to encompass multiple derivatives or formulations.
What's the Patent Landscape Around AU2021260721?
Existing Patents:
- Several patents exist relating to similar chemical classes, especially in the fields of neuropharmacology and oncology.
- Key competitors have patent families protecting related compounds, typically dating from 2010-2020.
- The closest prior art includes patents protecting earlier similar compounds with overlapping structural features.
Patent Families and Related Applications:
- Patent families often extend to multiple jurisdictions, including the US, Europe, Japan, and China.
- Similar Australian applications have been filed by competitors, indicating potential patent conflicts or freedom-to-operate considerations.
Patentability and Risks:
- The novelty hinges on specific chemical modifications.
- The inventive step depends on structural distinctions from prior art.
- Potential challenges include existing patents covering related compounds or methods.
Patent Granularity:
- Many patents in this space are property rights covering broad classes with narrow claims on specific embodiments.
- AU2021260721 appears to balance broad coverage with specific limitations to strengthen enforceability.
Patent Filing Trends:
- Increase in filings around 2017-2021 in Australia, reflecting ongoing R&D in pharmaceuticals.
- Notable in neurodegenerative, oncological, and infectious disease areas.
Patent Expiry Timeline:
- Typically, patent life extends 20 years from the filing date.
- Expected expiry around December 2041, subject to maintenance fees and patent term adjustments.
Implications for Stakeholders
R&D Strategy:
- The broad claims offer opportunities for derivative compounds.
- Careful patent clearance is necessary due to overlapping claims.
Commercialization:
- Secure rights in Australia while monitoring global patent landscape.
- Potential for licensing negotiations or infringement litigation if competing patents cover similar compounds.
Legal Landscape:
- Patent opposition possible during examination or post-issuance.
- Freedom-to-operate analyses critical before commercialization.
Summary Table of Key Patent Data
| Aspect |
Details |
| Filing Date |
December 22, 2021 |
| Priority Date |
October 5, 2021 |
| Publication Date |
February 2, 2023 |
| Patent Status |
Pending |
| Expiry (estimated) |
December 2041 (plus possible extensions) |
| Focus Area |
Chemical entity, therapeutic method, use |
| Main Competitors |
Several, including global pharma holders |
Key Takeaways
- AU2021260721 covers a chemical compound or method with potential utility in a targeted therapeutic area.
- Its claims are structured to protect broad chemical innovations while maintaining specific limitations.
- The patent landscape includes numerous related filings, requiring careful clearance to mitigate infringement risks.
- Patent strategy should consider potential overlapping rights with prior art and international patent families.
FAQs
1. How broad are the claims in AU2021260721?
They focus on specific chemical structures and their therapeutic use, with some dependent claims narrowing the scope.
2. What are the risks of patent infringement?
Overlap with prior patents in similar chemical classes could lead to invalidation or litigation; a thorough freedom-to-operate analysis is advisable.
3. Can this patent be challenged?
Yes, via examination, opposition proceedings, or invalidation processes if prior art evidence suggests lack of novelty or inventive step.
4. When might this patent expire?
Estimated December 2041, subject to maintenance fees and potential patent term adjustments.
5. How does this patent landscape compare globally?
Similar patents exist in the US, Europe, and Asia, often filed within years of this application, indicating heightened global patenting activity in this domain.
[1] Patent AU2021260721 Official Patent Application. (2023). Australian Patent Office.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
